Targeting the Neurobiology of RRB in Autism Using N-acetylcysteine: Single-dose

Clinical trial NCT04278898 · RECRUITING

Trial details

NCT number: NCT04278898
Sponsor: Stanford University
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Autism Spectrum Disorder

Start date: 2021-02-12
Primary completion: 2028-07-31
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.